BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18514721)

  • 1. Seeing (RED).
    Ellis SS
    Lancet; 2008 May; 371(9627):1835; author reply 1836. PubMed ID: 18514721
    [No Abstract]   [Full Text] [Related]  

  • 2. Seeing (RED).
    Feachem R
    Lancet; 2008 May; 371(9627):1835; author reply 1836. PubMed ID: 18514720
    [No Abstract]   [Full Text] [Related]  

  • 3. New fund-raising scheme fuses profit with philanthropy.
    Dyer O
    Bull World Health Organ; 2006 Apr; 84(4):263-4. PubMed ID: 16628295
    [No Abstract]   [Full Text] [Related]  

  • 4. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract]   [Full Text] [Related]  

  • 5. Losing the war on AIDS.
    Conant M
    J Am Acad Dermatol; 2004 Jul; 51(1 Suppl):S47-8. PubMed ID: 15243509
    [No Abstract]   [Full Text] [Related]  

  • 6. Are private dollars for research shifting diseases?
    Miller M
    J Natl Cancer Inst; 2001 Feb; 93(4):264-5. PubMed ID: 11181772
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV/AIDS prevention and treatment.
    Goemaere E; Ford N; Benatar SR
    Lancet; 2002 Jul; 360(9326):86-7; author reply 87-8. PubMed ID: 12114064
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent injustice: how India brought cheap HIV drugs to Africa.
    Menghaney L
    BMJ; 2013 Nov; 347():f7013. PubMed ID: 24277626
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS now world's fourth biggest killer.
    Balter M
    Science; 1999 May; 284(5417):1101. PubMed ID: 10366338
    [No Abstract]   [Full Text] [Related]  

  • 10. AIDS funding.
    Ojcius D
    Nat Rev Microbiol; 2004 Oct; 2(10):777. PubMed ID: 15468462
    [No Abstract]   [Full Text] [Related]  

  • 11. More effective & less costly AIDS health services.
    Altman D
    Caring; 1986 Jun; 5(6):52-5. PubMed ID: 10277289
    [No Abstract]   [Full Text] [Related]  

  • 12. WHO admits its target on AIDS drugs may be unrealistic.
    Fleck F
    BMJ; 2004 May; 328(7449):1151. PubMed ID: 15142896
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS and money. Where do we go from here?
    Engel J
    N C Med J; 1998; 59(6):344-7. PubMed ID: 9828620
    [No Abstract]   [Full Text] [Related]  

  • 14. Bush declines to support drug companies' line on AIDS profits.
    Dickson D
    Nature; 2001 Mar; 410(6824):3. PubMed ID: 11241998
    [No Abstract]   [Full Text] [Related]  

  • 15. A firm response to AIDS.
    Nature; 2006 Oct; 443(7113):738-9. PubMed ID: 17051178
    [No Abstract]   [Full Text] [Related]  

  • 16. Advisors to UN AIDS fund warn that providing antiretrovirals is not enough.
    McLellan F
    Lancet; 2001 Nov; 358(9293):1621. PubMed ID: 11716904
    [No Abstract]   [Full Text] [Related]  

  • 17. Beyond Barcelona--the global response to HIV.
    Steinbrook R
    N Engl J Med; 2002 Aug; 347(8):553-4. PubMed ID: 12192013
    [No Abstract]   [Full Text] [Related]  

  • 18. Fund-raising. Musicians to provide hope to AIDS orphans.
    AIDS Policy Law; 2005 Apr; 20(7):1. PubMed ID: 15880855
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug pricing. AHF to file suit against Glaxo for African AIDS-related deaths.
    AIDS Policy Law; 2003 Dec; 18(22):5. PubMed ID: 14974398
    [No Abstract]   [Full Text] [Related]  

  • 20. The Bush Administration's global AIDS promises--and praxis.
    Russell A
    Yale J Health Policy Law Ethics; 2004; 4(1):133-45. PubMed ID: 15052864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.